Company Description
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally.
It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process.
The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services.
In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform.
The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001.
Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
| Country | United States |
| Founded | 1992 |
| IPO Date | Aug 7, 2001 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 3,580 |
| CEO | Randall Lipps |
Contact Details
Address: 4220 North Freeway Fort Worth, Texas 76137 United States | |
| Phone | 877 415 9990 |
| Website | omnicell.com |
Stock Details
| Ticker Symbol | OMCL |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000926326 |
| CUSIP Number | 68213N109 |
| ISIN Number | US68213N1090 |
| Employer ID | 94-3166458 |
| SIC Code | 3571 |
Key Executives
| Name | Position |
|---|---|
| Randall A. Lipps | Founder, Executive Chairman, President and Chief Executive Officer |
| Nnamdi N. Njoku | Executive Vice President and Chief Operating Officer |
| Corey J. Manley J.D. | Executive Vice President, Chief Legal and Administrative Officer and Corporate Secretary |
| H. Baird Radford III | Executive Vice President and Chief Financial Officer |
| Brian H. Nutt | Vice President, Chief Accounting Officer and Corporate Controller |
| Dr. Perry A. Genova Ph.D. | Senior Vice President and Chief Technology Officer |
| Kathleen Nemeth | Senior Vice President of Investor Relations |
| Tomer Stavitsky | Senior Vice President and Chief Corporate Development Officer |
| Stella Prefach | Senior Vice President and Chief Marketing Officer |
| Dave Ford | SVice President and Chief People Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 16, 2026 | 144 | Filing |
| Feb 26, 2026 | 10-K | Annual Report |
| Feb 17, 2026 | 144 | Filing |
| Feb 5, 2026 | 8-K | Current Report |
| Jan 8, 2026 | 144 | Filing |
| Dec 16, 2025 | 144 | Filing |
| Dec 8, 2025 | 8-K | Current Report |
| Dec 3, 2025 | 144 | Filing |
| Dec 1, 2025 | 144 | Filing |
| Nov 17, 2025 | 144 | Filing |